Philippe Camus, M.D.

Dijon, France

Back to drug

The Drug-Induced Respiratory Disease Website

XI.a

Pulmonary arterial hypertension

Will reverse in some patients upon drug discontinuance

Publications

Han HJ, Hong KT, Choi JY, Lee SY, Kang HJ

Dasatinib-induced reversible pulmonary arterial hypertension in a pediatric patient with BCR/ABL1+ lymphoblastic lymphoma from chronic myeloid leukemia.

Blood research 2022 Mar 04;; — 2022 Mar 04

Tamura Y, Tamura Y

Dasatinib-induced Pulmonary Hypertension.

Internal medicine (Tokyo, Japan) 2022 Feb 01;; — 2022 Feb 01

Zeb H, El-Kersh K

Dasatinib-Induced Pulmonary Arterial Hypertension.

American journal of therapeutics 2020 Aug 03;; — 2020 Aug 03

Nishimori M, Honjo T, Kaihotsu K, Sone N, Yoshikawa S, Imanishi J, Nakayama K, Emoto N, Iwahashi M

Dasatinib-Induced Pulmonary Arterial Hypertension Treated with Upfront Combination Therapy.

Case reports in cardiology 2018;2018;3895197 — 2018 — 3895197

Makeeva LM, Emelina EI, Gendlin GE, Nikitin IG, Vasyuk YA, Nesvetov VV

[Pulmonary arterial hypertension and chronic heart failure as dasatinib cardiotoxicity. A case report].

Kardiologiia 2017 04;57;53-60 — 2017 04 — 53-60

Özgür Yurtta? N, E?kazan AE

Dasatinib-induced pulmonary arterial hypertension.

British journal of clinical pharmacology 2018 05;84;835-845 — 2018 05 — 835-845

Weatherald J, Chaumais MC, Savale L, Jaïs X, Seferian A, Canuet M, Bouvaist H, Magro P, Bergeron A, Guignabert C, Sitbon O, Simonneau G, Humbert M, Montani D

Long-term outcomes of dasatinib-induced pulmonary arterial hypertension: a population-based study.

The European respiratory journal 2017 07;50; — 2017 07

Shah NP, Wallis N, Farber HW, Mauro MJ, Wolf RA, Mattei D, Guha M, Rea D, Peacock A

Clinical features of pulmonary arterial hypertension in patients receiving dasatinib.

American journal of hematology 2015 Nov;90;1060-4 — 2015 Nov — 1060-4

Yun S, Anwer F, Vincelette ND

Dasatinib-induced pulmonary hypertension in chronic myelogenous leukaemia.

BMJ case reports 2014 Apr 15;2014; — 2014 Apr 15

Groeneveldt JA, Gans SJ, Bogaard HJ, Vonk-Noordegraaf A

Dasatinib-induced pulmonary arterial hypertension unresponsive to PDE-5 inhibition.

The European respiratory journal 2013 Sep;42;869-70 — 2013 Sep — 869-70

Kim JC, Shin SH, Yi HG, Kim SH, Woo SI, Kim DH, Park KS, Kwan J

Rapid-onset pulmonary arterial hypertension in a patient with acute lymphoblastic leukemia treated with dasatinib.

Herz 2013 Dec;38;931-3 — 2013 Dec — 931-3

Sano M, Saotome M, Urushida T, Katoh H, Satoh H, Ohnishi K, Hayashi H

Pulmonary arterial hypertension caused by treatment with dasatinib for chronic myeloid leukemia -critical alert-.

Internal medicine (Tokyo, Japan) 2012;51;2337-40 — 2012 — 2337-40

Breccia M, Efficace F, Alimena G

Progressive arterial occlusive disease (PAOD) and pulmonary arterial hypertension (PAH) as new adverse events of second generation TKIs in CML treatment: who's afraid of the big bad wolf?

Leukemia research 2012 Jul;36;813-4 — 2012 Jul — 813-4

Montani D, Bergot E, Günther S, Savale L, Bergeron A, Bourdin A, Bouvaist H, Canuet M, Pison C, Macro M, Poubeau P, Girerd B, Natali D, Guignabert C, Perros F, O'Callaghan DS, Jaïs X, Tubert-Bitter P, Zalcman G, Sitbon O, Simonneau G, Humbert M

Pulmonary arterial hypertension in patients treated by dasatinib.

Circulation 2012 May 01;125;2128-37 — 2012 May 01 — 2128-37

Orlandi EM, Rocca B, Pazzano AS, Ghio S

Reversible pulmonary arterial hypertension likely related to long-term, low-dose dasatinib treatment for chronic myeloid leukaemia.

Leukemia research 2012 Jan;36;e4-6 — 2012 Jan — e4-6

Dumitrescu D, Seck C, ten Freyhaus H, Gerhardt F, Erdmann E, Rosenkranz S

Fully reversible pulmonary arterial hypertension associated with dasatinib treatment for chronic myeloid leukaemia.

The European respiratory journal 2011 Jul;38;218-20 — 2011 Jul — 218-20

Hennigs JK, Keller G, Baumann HJ, Honecker F, Kluge S, Bokemeyer C, Brümmendorf TH, Klose H

Multi tyrosine kinase inhibitor dasatinib as novel cause of severe pre-capillary pulmonary hypertension?

BMC pulmonary medicine 2011 May 23;11;30 — 2011 May 23 — 30

Mattei D, Feola M, Orzan F, Mordini N, Rapezzi D, Gallamini A

Reversible dasatinib-induced pulmonary arterial hypertension and right ventricle failure in a previously allografted CML patient.

Bone marrow transplantation 2009 Jun;43;967-8 — 2009 Jun — 967-8